![Will Shell make the Brexit case in first-quarter earnings?](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEHAE0CL_L.jpg)
Please try another search
Lexaria Bioscience Corp. reported earnings results for the second quarter and six months ended February 29, 2024. For the second quarter, the company reported sales was USD 0.145 million compared to USD 0.020025 million a year ago. Net loss was USD 0.649539 million compared to USD 1.3 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.22 a year ago. Diluted loss per share from continuing operations was USD 0.06 compared to USD 0.22 a year ago.For the six months, sales was USD 0.296278 million compared to USD 0.11776 million a year ago. Net loss was USD 1.83 million compared to USD 3.05 million a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.52 a year ago. Diluted loss per share from continuing operations was USD 0.18 compared to USD 0.52 a year ago.
Period Ending: | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 |
---|---|---|---|---|
Total Revenue | 0.145 | 0.151 | -0.003 | 0.093 |
Gross Profit | 0.145 | 0.146 | -0.003 | 0.08 |
Operating Income | -0.668 | -1.14 | -1.07 | -2.38 |
Net Income | -0.65 | -1.18 | -1.24 | -2.37 |
Period Ending: | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 |
---|---|---|---|---|
Total Assets | 6.35 | 3.63 | 3.08 | 5.24 |
Total Liabilities | 0.204 | 0.254 | 0.404 | 1.2 |
Total Equity | 6.15 | 3.37 | 2.68 | 4.04 |
Period Ending: | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -0.62 | -1.18 | -1.62 | -1.79 |
Cash From Investing Activities | -0.057 | -0.04 | -0.068 | -0.034 |
Cash From Financing Activities | 3.45 | 1.82 | -0.122 | 1.71 |
Net Change in Cash | 2.75 | 0.602 | -1.81 | -0.108 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review